Allozyne
Seattle, US
Founders & leadership
DT
David TirrellFounder
MC
Meenu ChhabraExecutive
JB
John BencichExecutive
KG
Kenneth GrabsteinExecutive
Board
CW
Carl WeissmanBoard director
SG
Steven GillisBoard director
MS
Michael SteinmetzBoard director
Reported raises · per SEC filings
Form D private placements$2.5M disclosed across 1 round · 2012
▶$2.5MraisedFeb 2012 · 5 investors · BiotechnologyRule 506(b)
▶$2.5MraisedFeb 2012 · 5 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Meenu ChhabraExecutive Officer, Director
- Carl WeissmanDirector
- Steven GillisDirector
- John BencichExecutive Officer
- Michael SteinmetzDirector
- David TirrellDirector
- Kenneth GrabsteinExecutive Officer
- Offering amount
- $4M
- Amount sold
- $2.5M
- First sale
- Jan 2012
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who founded Allozyne?
- Allozyne was founded by David Tirrell.
- How much funding has Allozyne raised?
- Allozyne has disclosed $2.5M raised across 1 round.
- Where is Allozyne headquartered?
- Allozyne is headquartered in Seattle, US.